2024: The year to take European action on diabetes to the next level Stefano Del PratoBart Torbeynson behalf of the European Diabetes Forum Board News 18 May 2024 Pages: 1155 - 1158
New guideline of the European Medicines Agency (EMA) on the clinical investigation of medicinal products in the treatment and prevention of diabetes mellitus Bart Van der SchuerenPatrick VrijlandtKristina Dunder News 04 May 2024 Pages: 1159 - 1162
Bo Hellman, 19 June 1930–4 December 2023 Erik GylfeAnders Tengholm In memoriam 25 April 2024 Pages: 1165 - 1167
Diabetes and infection: review of the epidemiology, mechanisms and principles of treatment Richard I. G. HoltClive S. CockramAndrea O. Y. Luk Review Open access 20 February 2024 Pages: 1168 - 1180
The insulin resistant brain: impact on whole-body metabolism and body fat distribution Martin Heni Review Open access 16 February 2024 Pages: 1181 - 1191
Prevention and treatment of ischaemic and haemorrhagic stroke in people with diabetes mellitus: a focus on glucose control and comorbidities Simona SaccoMatteo FoschiMichele Romoli Review Open access 16 April 2024 Pages: 1192 - 1205
Subcutaneously administered tirzepatide vs semaglutide for adults with type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials Thomas KaragiannisKonstantinos MalandrisEleni Bekiari Article Open access 13 April 2024 Pages: 1206 - 1222
Continuous glucose monitoring with structured education in adults with type 2 diabetes managed by multiple daily insulin injections: a multicentre randomised controlled trial Ji Yoon KimSang-Man JinJae Hyeon Kim Article 19 April 2024 Pages: 1223 - 1234
Comparison between a tubeless, on-body automated insulin delivery system and a tubeless, on-body sensor-augmented pump in type 1 diabetes: a multicentre randomised controlled trial Ji Yoon KimSang-Man JinJae Hyeon Kim Article 18 April 2024 Pages: 1235 - 1244
Integration of a fasting-mimicking diet programme in primary care for type 2 diabetes reduces the need for medication and improves glycaemic control: a 12-month randomised controlled trial Elske L. van den BurgMarjolein P. SchoonakkerHanno Pijl Article Open access 28 March 2024 Pages: 1245 - 1259
Impact of the timing of metformin administration on glycaemic and glucagon-like peptide-1 responses to intraduodenal glucose infusion in type 2 diabetes: a double-blind, randomised, placebo-controlled, crossover study Cong XiePeter IrogaTongzhi Wu Article Open access 01 April 2024 Pages: 1260 - 1270
Risk of diabetic retinopathy and diabetic macular oedema with sodium–glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists in type 2 diabetes: a real-world data study from a global federated database Aikaterini EleftheriadouDavid RileyUazman Alam Article Open access 08 April 2024 Pages: 1271 - 1282
Non-adherence to cardiometabolic medication as assessed by LC-MS/MS in urine and its association with kidney and cardiovascular outcomes in type 2 diabetes mellitus Sara DenicolòVera ReinstadlerGert Mayer Article Open access 22 April 2024 Pages: 1283 - 1294
Threshold of hyperglycaemia associated with mortality in critically ill patients: a multicentre, prospective, observational study using continuous glucose monitoring Yaxin WangSiwan LiJian Zhou Article Open access 03 April 2024 Pages: 1295 - 1303
Can the introduction of a 12-lead ECG help reduce mortality in those presenting with foot ulceration to multidisciplinary diabetic foot clinics? An observational evaluation of a real-world implementation pilot in England Jonathan ValabhjiNaomi HolmanKetan Dhatariya Article Open access 08 April 2024 Pages: 1304 - 1314
Gestational age at birth and type 1 diabetes in childhood and young adulthood: a nationwide register study in Finland, Norway and Sweden Johanna MetsäläKari RisnesEero Kajantie Article Open access 13 April 2024 Pages: 1315 - 1327
Effectiveness and safety of empagliflozin: final results from the EMPRISE study Phyo T. HtooHelen TesfayeElisabetta Patorno Article 21 March 2024 Pages: 1328 - 1342
Trajectories of clinical characteristics, complications and treatment choices in data-driven subgroups of type 2 diabetes Xinyu LiLouise A. DonnellyTalitha Feenstra Article Open access 16 April 2024 Pages: 1343 - 1355
Associations of 24 h time-use compositions of sitting, standing, physical activity and sleeping with optimal cardiometabolic risk and glycaemic control: The Maastricht Study Christian J. BrakenridgeAnnemarie KosterDavid W. Dunstan Article Open access 24 April 2024 Pages: 1356 - 1367
CK2 activity is crucial for proper glucagon expression Emmanuel AmpofoMandy PackClaudia Götz Extended Article Open access 20 March 2024 Pages: 1368 - 1385
Exercise-induced increase in muscle insulin sensitivity in men is amplified when assessed using a meal test Christian T. VoldstedlundKim A. SjøbergErik A. Richter Article Open access 25 April 2024 Pages: 1386 - 1398
Short-term effects of obesity surgery versus low-energy diet on body composition and tissue-specific glucose uptake: a randomised clinical study using whole-body integrated 18F-FDG-PET/MRI Jan W. ErikssonMaria J. PereiraHåkan Ahlström Article Open access 24 April 2024 Pages: 1399 - 1412
The metabolome as a diagnostic for maximal aerobic capacity during exercise in type 1 diabetes Guy S. TaylorKieran SmithLee D. Roberts Article Open access 25 April 2024 Pages: 1413 - 1428
ACSF2 and lysine lactylation contribute to renal tubule injury in diabetes Jingfang ChenQi FengZhangsuo Liu Article 27 April 2024 Pages: 1429 - 1443
An unclear role for the GLP-1 metabolite GLP-1(9–36) in human islet physiology Aleksey MatveyenkoAdrian Vella Letter 06 April 2024 Pages: 1444 - 1445
An unclear role for the GLP-1 metabolite GLP-1(9–36) in human islet physiology. Reply to Matveyenko A, Vella A [letter] Nikhil R. GandasiPatrik Rorsman Letter 05 April 2024 Pages: 1446 - 1447
Should children with type 1 diabetes really receive statin treatment using the same criteria as for children with familial hypercholesterolaemia? Reply to Sánchez‑Hernández and Wägner [letter] Willemijn E. CorpeleijnWouter J. de WaalAlbert Wiegman Letter 13 May 2024 Pages: 1448 - 1449
Correction to: Occurrence of corneal sub-epithelial microneuromas and axonal swelling in people with diabetes with and without (painful) diabetic neuropathy Eva Sierra‑SilvestreRicardo J. AndradeMichel W. Coppieters Correction Open access 05 April 2024 Pages: 1450 - 1450
Correction: Separate and combined effects of semaglutide and empagliflozin on kidney oxygenation and perfusion in people with type 2 diabetes: a randomised trial Søren GullaksenLiv VernstrømEsben Laugesen Correction 13 May 2024 Pages: 1451 - 1451
